FASENRA SCEI for long-term use

Trial Identifier:	D3250C00057
Sponsor:	AstraZeneca
Start Date:	May 2018
Primary Completion Date:	September 2024
Study Completion Date:	September 2024
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Akita, Japan, D3250C00057
Japan	Iwate, Japan, D3250C00057
Japan	Shiga, Japan, D3250C00057
Japan	Yamagata, Japan, D3250C00057

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.